Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

N-glycosylation as a regulator of Grp94 Function and Activity

Award Number: R01GM152842
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2024
PERIOD OF PERFORMANCE END DATE: 01/31/2025

Group Awards By:

View Award Description

N-glycosylation as a regulator of Grp94 Function and Activity - PROJECT SUMMARY Most newly synthesized proteins destined for the cell surface or secretion must transit through the endoplasmic reticulum (ER) for folding and post-translational processing. Grp94, the ER resident member of the hsp90 family of chaperones, is required for the maturation of various membrane and secreted proteins. Grp94's control over the fate of these diverse clients makes it an emerging therapeutic target for a number of chronic diseases including type 2 diabetes, familial hypercholesterolemia, and sepsis, as well as cancers such as HER2-positive breast cancer and multiple myeloma. An unanswered question is how Grp94 adapts to different needs within a dynamic ER folding environment to ensure efficient client capture and folding. Despite being the most abundant protein in the ER, Grp94 is even further upregulated under conditions of cell stress or disease. The increased overexpression of Grp94 correlates with its hyperglycosylation, the utilization of the five minor glycosylation sites that are sparingly occupied in nonstressed cells and tissues. Recent studies have shown that hyperglycosylation imparts new functions to Grp94 that are essential for the successful response to stress or maintenance of the pathological state. Our central hypothesis is that differential glycosylation serves as a tuning mechanism that alters the functional status of Grp94. A systematic analysis of the effects of glycosylation on Grp94 has been hampered by the difficulty in producing site-specific, homogeneous glycoproteins that would allow for the clear interpretation of functional and biochemical assays. Here we propose to study how the activity of Grp94 is regulated by glycosylation and to visualize the capture of a client protein. We will make use of a novel in-cell expression system developed in our lab that allows us to selectively control the glycosylation patterns of Grp94 at all available sequons. We will employ these defined glycosylated species in both in vivo and in vitro Grp94-specific assays that allows for the interrogation of Grp94 activity as a function of attached glycans. Combined with structural and biochemical tools, we expect to determine how glycosylation regulates the structure and function of Grp94 and how a client protein is captured by the chaperone.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $288,331 )
2025	2025	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	520 LEE ENTRANCE STE 211	AMHERST	NY	14228	ERIE	USA	Biomedical Research and Research Training	002	3	9/4/2025	NON-COMPETING CONTINUATION	$322,000
2025	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	000	1	7/17/2025	NEW	-$197,929
2025	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	003	1	9/9/2025	NEW	$0
2025	2024	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	520 LEE ENTRANCE STE 211	AMHERST	NY	14228	ERIE	USA	Biomedical Research and Research Training	001	2	7/17/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$164,260
														Subtotal = $288,331

Issue Date FY: 2024 ( Subtotal = $388,000 )
2024	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	000	1	8/13/2024	NEW	$388,000
														Subtotal = $388,000

Grand Total All Awards = $676,331

Top

All Categories

About

Search

Reports

Data Submission

Award Information

N-glycosylation as a regulator of Grp94 Function and Activity

Award Number: R01GM152842

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2024

PERIOD OF PERFORMANCE END DATE: 01/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer